VentriPoint Diagnostics Ltd (VPT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, VentriPoint Diagnostics Ltd (VPT) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-95.70K ≈ $-69.23K USD) by net assets (CA$-4.66 Million ≈ $-3.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VentriPoint Diagnostics Ltd (VPT) net asset quality to measure how much of total assets are equity-financed.

VentriPoint Diagnostics Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how VentriPoint Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check VentriPoint Diagnostics Ltd (VPT) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

VentriPoint Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of VentriPoint Diagnostics Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kresna Graha Investama Tbk PT
JK:KREN
0.008x
CTRL Group Limited Ordinary Shares
NASDAQ:MCTR
-0.546x
Panca Global Securities Tbk
JK:PEGE
-0.129x
Vichitbhan Palmoil Public Company Limited
BK:VPO
-0.267x
Lena Lighting S.A.
WAR:LEN
-0.024x
Cassius Mining Ltd
AU:CMD
-0.253x
Minox International Group Berhad
KLSE:0288
0.026x
Volution Group plc
LSE:FAN
0.147x

Annual Cash Flow Conversion Efficiency for VentriPoint Diagnostics Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of VentriPoint Diagnostics Ltd from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see VentriPoint Diagnostics Ltd (VPT) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$-2.98 Million
≈ $-2.16 Million
CA$-3.39 Million
≈ $-2.45 Million
1.136x +105.66%
2023-12-31 CA$189.71K
≈ $137.23K
CA$-3.80 Million
≈ $-2.75 Million
-20.052x -2107.17%
2022-12-31 CA$4.55 Million
≈ $3.29 Million
CA$-4.14 Million
≈ $-2.99 Million
-0.908x -140.60%
2021-12-31 CA$8.33 Million
≈ $6.03 Million
CA$-3.15 Million
≈ $-2.28 Million
-0.378x -180.59%
2020-12-31 CA$-2.35 Million
≈ $-1.70 Million
CA$-1.10 Million
≈ $-795.98K
0.469x -51.41%
2019-12-31 CA$-2.47 Million
≈ $-1.79 Million
CA$-2.38 Million
≈ $-1.72 Million
0.964x -69.22%
2018-12-31 CA$-973.26K
≈ $-704.04K
CA$-3.05 Million
≈ $-2.21 Million
3.133x +65.95%
2017-12-31 CA$-1.63 Million
≈ $-1.18 Million
CA$-3.07 Million
≈ $-2.22 Million
1.888x +93.11%
2016-12-31 CA$-2.25 Million
≈ $-1.63 Million
CA$-2.20 Million
≈ $-1.59 Million
0.978x -83.62%
2015-12-31 CA$-269.66K
≈ $-195.07K
CA$-1.61 Million
≈ $-1.16 Million
5.967x +1033.35%
2014-12-31 CA$-2.40 Million
≈ $-1.73 Million
CA$-1.26 Million
≈ $-912.31K
0.526x -36.40%
2013-12-31 CA$-3.12 Million
≈ $-2.26 Million
CA$-2.58 Million
≈ $-1.87 Million
0.828x -49.84%
2012-12-31 CA$-2.65 Million
≈ $-1.92 Million
CA$-4.37 Million
≈ $-3.16 Million
1.650x -3.38%
2011-12-31 CA$-2.33 Million
≈ $-1.68 Million
CA$-3.98 Million
≈ $-2.88 Million
1.708x -27.65%
2010-12-31 CA$-860.17K
≈ $-622.24K
CA$-2.03 Million
≈ $-1.47 Million
2.360x +434.52%
2009-12-31 CA$-3.26 Million
≈ $-2.36 Million
CA$-1.44 Million
≈ $-1.04 Million
0.442x -80.32%
2008-12-31 CA$-1.87 Million
≈ $-1.35 Million
CA$-4.20 Million
≈ $-3.04 Million
2.244x +682.50%
2007-12-31 CA$2.50 Million
≈ $1.81 Million
CA$-965.08K
≈ $-698.12K
-0.385x -590.65%
2006-12-31 CA$670.44K
≈ $484.98K
CA$-37.40K
≈ $-27.06K
-0.056x -886.77%
2005-12-31 CA$695.36K
≈ $503.01K
CA$-3.93K
≈ $-2.84K
-0.006x --

About VentriPoint Diagnostics Ltd

V:VPT Canada Medical Devices
Market Cap
$14.93 Million
CA$20.64 Million CAD
Market Cap Rank
#26026 Global
#1037 in Canada
Share Price
CA$0.11
Change (1 day)
-4.35%
52-Week Range
CA$0.08 - CA$0.17
All Time High
CA$0.69
About

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provid… Read more